Cargando…
Transplantation of CD34+ cells for myocardial ischemia
CD34+ cells are multipotent hematopoietic stem cells also known as endothelial progenitor cells and are useful in regenerative medicine. Naturally, these cells are mobilized from the bone marrow into peripheral circulation in response to ischemic tissue injury. CD34+ cells are known for their high p...
Autores principales: | Matta, Anthony, Nader, Vanessa, Galinier, Michel, Roncalli, Jerome |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131931/ https://www.ncbi.nlm.nih.gov/pubmed/34046316 http://dx.doi.org/10.5500/wjt.v11.i5.138 |
Ejemplares similares
-
Coronary artery aneurysm: A review
por: Matta, Anthony Georges, et al.
Publicado: (2021) -
Pre-Conditioning Methods and Novel Approaches with Mesenchymal Stem Cells Therapy in Cardiovascular Disease
por: Matta, Anthony, et al.
Publicado: (2022) -
Evaluation of Mitral and Aortic Valvular Disease and Left Ventricular Dysfunction in a Lebanese Population: Retrospective Single-Center Experience
por: Nader, Vanessa, et al.
Publicado: (2021) -
Benefits of Interventional Telemonitoring on Survival and Unplanned Hospitalization in Patients With Chronic Heart Failure
por: Galinier, Michel, et al.
Publicado: (2022) -
Mortality rate after coronary revascularization in heart failure patients with coronary artery disease
por: Nader, Vanessa, et al.
Publicado: (2023)